Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Dec 7, 2017 in Melanoma | 0 comments

In a nutshell

This study investigated the impact of the time between diagnosis and sentinel lymph node biopsy (SLNB) in melanoma outcomes. Researchers suggested that no negative effects are associated with delayed SLNB. 

Some background

SLNB is a procedure used to detect lymph node metastasis (spread disease) in melanoma patients. The standard treatment for early skin melanoma is surgery and SLNB. However, the effects of delayed SLNB are not clear. Prior studies showed that delayed surgeries allowed a better immune response against cancer cells. 

Methods & findings

This study included information on 2483 patients with early melanoma. Of these, 42% had delayed SLNB (30 or more days after diagnosis) and 37% had early SLNB (30 days or less). 17.4 % of these patients were positive for SLNB. 

There was no difference in melanoma-specific survival between those undergoing early or delayed SLNB. 

The bottom line

This study determined that no negative effect is associated with delayed SLNB beyond 30 days in early melanoma. 

Published By :

Journal of the American College of Surgeons

Date :

Jun 16, 2017

Original Title :

Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.

click here to get personalized updates